Medicine quality and AMR
The Ministry of Health’s 1 July 2026 report describes national action against substandard and falsified medical products. It connects medicine quality with treatment failure and AMR, and outlines the roles of regulation, surveillance and inter-agency coordination.
Protecting effective treatment
Quality-assured medicines and responsible use both support effective treatment. Programme teams, regulators and medicine-supply stakeholders contribute to this work alongside healthcare professionals.
Antimicrobial stewardship connects appropriate treatment with medicine quality and responsible use. For questions about an individual medicine, speak to a qualified pharmacist or the healthcare professional responsible for your care.